20 декабрь 2023
Sofia, Bulgaria, December 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that for the month of November 2023, the Company realized a decrease in sales of 20% compared to the same month of the previous year, incl. 11% decrease in domestic sales and 26% decrease in export sales.
For the eleven months from the beginning of 2023, sales increased by a total of 14%, incl. a 3% increase in domestic sales and a 21% increase in export sales.